Fluconazole
Fluconazole Polfarmex belongs to a group of antifungal medicines. The active substance is fluconazole.
Fluconazole Polfarmex is used to treat infections caused by pathogenic fungi and can also be used to prevent yeast infections. The most common cause of fungal infections is yeast of the genus Candida.
The doctor may recommend taking this medicine for the following fungal infections:
Fluconazole Polfarmex can also be used to:
The doctor may recommend taking this medicine to treat the following fungal infections:
Fluconazole Polfarmex can also be used to:
Tell your doctor if:
Tell your doctor or pharmacist about all medicines the patient is taking, has recently taken, or plans to take.
Immediately tell your doctor about taking astemizole, terfenadine (antihistamines used to treat allergies), or cisapride (used to treat stomach disorders), or pimozide (used to treat mental disorders), or quinidine (used to treat heart rhythm disorders), or erythromycin (an antibiotic used to treat infections), as they should not be taken with Fluconazole Polfarmex (see "When not to take Fluconazole Polfarmex").
There are also other medicines that may interact with Fluconazole Polfarmex.
If the patient is taking any of the following medicines, they should make sure their doctor is informed:
The medicine can be taken with or without food.
If the patient is pregnant or breastfeeding, thinks they may be pregnant, or plans to have a child, they should consult their doctor before taking this medicine.
If the patient plans to become pregnant, it is recommended to wait one week after taking a single dose of fluconazole before becoming pregnant. In case of longer treatment cycles with fluconazole, the patient should discuss the need for appropriate contraception during treatment and for one week after the last dose with their doctor.
If the patient is pregnant, thinks they may be pregnant, or is trying to become pregnant, they should not take fluconazole unless their doctor recommends it. If the patient becomes pregnant or thinks they may be pregnant while taking this medicine or within one week of taking the last dose, they should contact their doctor.
Fluconazole taken during the first or second trimester of pregnancy may increase the risk of miscarriage. Fluconazole taken during the first trimester of pregnancy may increase the risk of birth defects of the heart, bones, and/or muscles.
There have been reports of children with birth defects of the skull, ears, and thigh and forearm bones, born to mothers treated for coccidioidomycosis with high doses of fluconazole (400-800 mg per day) for at least 3 months. The relationship between fluconazole use and these cases is unclear.
Breastfeeding
The medicine passes into human milk at concentrations lower than in serum. Breastfeeding can be continued after a standard single dose of 200 mg or less. Breastfeeding is not recommended after taking multiple doses of fluconazole or after taking a high dose.
When driving or operating machinery, consider that dizziness or seizures may occasionally occur.
Fluconazole Polfarmex contains sorbitol (E 420), sucrose, sodium benzoate (E 211), sodium, glycerol, propylene glycol (E 1520), and citral (a component of strawberry flavor, liquid).
The medicine contains 3.5 g of sorbitol (E 420) per 10 mL of syrup. Sorbitol in a dose of 10 g or more may have a mild laxative effect. Caloric value: 2.6 kcal/g of sorbitol. Sorbitol is a source of fructose. If the patient (or their child) has previously been diagnosed with intolerance to some sugars or has a rare genetic disorder, hereditary fructose intolerance, in which the patient's body does not break down fructose, the patient should consult their doctor before taking the medicine or giving it to their child.
10 mL of syrup contains 4 g of sucrose. This should be taken into account in patients with diabetes.
If the patient has previously been diagnosed with intolerance to some sugars, they should consult their doctor before taking the medicine.
The medicine contains 20 mg of sodium benzoate (E 211) per 10 mL of syrup. Benzoic acid salt may increase the risk of jaundice (yellowing of the skin and eyes) in newborns (up to 4 weeks of age).
This medicine contains less than 1 mmol (23 mg) of sodium per 10 mL, which means the medicine is considered "sodium-free".
The medicine contains 0.68 g of glycerol per 10 mL of syrup.
The medicine may cause headache, stomach upset, and diarrhea.
10 mL of syrup contains 164.8 mg of propylene glycol (E 1520).
Before administering the medicine to a child under 4 weeks of age, consult a doctor or pharmacist, especially if the child is taking other medicines containing propylene glycol or alcohol.
Before administering the medicine to a child under 5 years of age, consult a doctor or pharmacist, especially if the child is taking other medicines containing propylene glycol or alcohol.
Pregnant or breastfeeding women should not take this medicine without their doctor's recommendation. The doctor may decide to perform additional tests on such patients.
Patients with liver or kidney function disorders should not take this medicine without their doctor's recommendation. The doctor may decide to perform additional tests on such patients.
A component of strawberry flavor, liquid.
Always take this medicine exactly as your doctor has told you. If you are not sure, check with your doctor or pharmacist.
It is best to take the medicine at the same time every day.
The recommended dosage, depending on the type of infection, is presented below.
Indication | Dosage |
Treatment of cryptococcal meningitis | 400 mg on the first day, then 200 mg to 400 mg once a day for 6 to 8 weeks or longer if necessary. Sometimes the dose is increased to 800 mg |
Prevention of relapses of cryptococcal meningitis | 200 mg once a day until the doctor recommends stopping treatment |
Treatment of coccidioidomycosis | 200 mg to 400 mg once a day for 11 months to 24 months or longer if necessary. Sometimes the dose may be increased to 800 mg |
Treatment of internal organ infections caused by Candida yeast | 800 mg on the first day, then 400 mg once a day until the doctor recommends stopping treatment |
Treatment of fungal infections of the mucous membranes of the mouth, throat, and mouth sores associated with the use of dental prostheses | 200 mg to 400 mg on the first day, then 100 mg to 200 mg until the doctor recommends stopping treatment |
Fungal infections of the mucous membranes - the dose depends on the location | 50 mg to 400 mg once a day for 7 to 30 days, until the doctor recommends stopping treatment |
Prevention of fungal infections of the mouth and throat | 100 mg to 200 mg once a day, or 200 mg 3 times a week, if the patient is at increased risk of relapse |
Treatment of fungal infections of the genital organs | A single dose of 150 mg |
Prevention of relapses of vaginal yeast infections | 150 mg every third day, for a total of 3 doses (days 1, 4, and 7), and then once a week for 6 months (if the patient is at increased risk of relapse) |
Treatment of fungal skin and nail infections | Depending on the location of the infection, 50 mg once a day, 150 mg once a week, 300 to 400 mg once a week for 1 to 4 weeks (in athlete's foot, treatment may be necessary for up to 6 weeks, in nail infections, treatment should be continued until the infected nail is replaced by a new one) |
Prevention of yeast infections (if the patient's immune system is weak and not functioning properly) | 200 to 400 mg once a day, if the patient is at increased risk of relapse |
The dose prescribed by the doctor should be taken (as for adult patients or as for children).
The maximum dose in children is 400 mg per day.
The dose will be determined based on the child's body weight in kilograms.
Indication | Daily dose |
Fungal infections of the mucous membranes of the mouth and throat - the dose and duration of treatment depend on the severity and location of the infection | 3 mg/kg of body weight (on the first day, a dose of 6 mg/kg of body weight can be given) |
Cryptococcal meningitis or fungal infections of internal organs | 6 to 12 mg/kg of body weight |
Prevention of yeast infections in children (if the immune system is not functioning properly) | 3 to 12 mg/kg of body weight |
Newborns from 3 to 4 weeks of age
The same dose as above, but given every other day. The maximum dose is 12 mg/kg of body weight every 48 hours.
Newborns under 2 weeks of age
The same dose as above, given every 3 days. The maximum dose is 12 mg/kg of body weight every 72 hours.
Sometimes the doctor may recommend a different dosage. The medicine should always be taken as recommended by the doctor. In case of doubts, consult a doctor or pharmacist.
The usual dose for adults is given, unless the patient has kidney function disorders.
The doctor may recommend changing the dosage, depending on kidney function.
Taking too high a dose of the medicine at one time may cause discomfort. Immediately contact the emergency department of the nearest hospital. Symptoms of possible overdose may include hearing, vision, or sensation disorders, thinking about untrue things (hallucinations and paranoid behaviors). Symptomatic treatment (life-sustaining treatment and stomach lavage, if necessary) may be indicated.
Do not take a double dose to make up for a missed dose. If a dose is missed, take it as soon as remembered. If it is almost time for the next dose, do not take the missed dose.
In case of any further doubts about taking this medicine, consult a doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Some patients may experience allergic reactions, but severe allergic reactions are rare. If any of the following symptoms occur, immediately tell your doctor:
Fluconazole Polfarmex may affect the liver. Symptoms of liver disorders include:
If any of these symptoms occur, stop taking Fluconazole Polfarmex and immediately contact your doctor.
Additionally, if any side effects worsen or if any side effects not listed in this leaflet occur, tell your doctor or pharmacist.
Common side effects (in 1 to 10 out of 100 patients):
Uncommon side effects (in 1 to 10 out of 1,000 patients):
Rare side effects (in 1 to 10 out of 10,000 patients):
If side effects occur, including those not listed in this leaflet, tell your doctor or pharmacist. Side effects can be reported directly to the Department of Drug Safety Monitoring of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products
Al. Jerozolimskie 181 C
02-222 Warsaw
Phone: +48 22 49 21 301
Fax: +48 22 49 21 309
Website: https://smz.ezdrowie.gov.pl
Side effects can also be reported to the marketing authorization holder.
Reporting side effects will help gather more information on the safety of the medicine.
Keep the medicine out of the sight and reach of children.
Store in a temperature below 25°C in the original packaging.
Protect from light.
After opening the package, the medicine should be used within 6 months.
Do not use this medicine after the expiry date stated on the carton and bottle after: "Expiry date" or "EXP". The expiry date refers to the last day of the month.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines that are no longer needed. This will help protect the environment.
Bottles made of brown glass or plastic with a capacity of 150 mL, in a cardboard box.
Polfarmex S.A.
ul. Józefów 9
99-300 Kutno
Phone: +48 24 357 44 44
Fax: +48 24 357 45 45
e-mail: polfarmex@polfarmex.pl
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.